| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/11/2012 | CN102574853A Heterocyclic oxime compounds |
| 07/11/2012 | CN102574852A AKT inhibitors |
| 07/11/2012 | CN102574851A Fused heterocyclic ring derivative and use thereof |
| 07/11/2012 | CN102574846A Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 07/11/2012 | CN102574845A 1h-imidazo[4,5-c]quinolinone derivatives |
| 07/11/2012 | CN102574843A Fused ring analogues of anti-fibrotic agents |
| 07/11/2012 | CN102574842A Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 07/11/2012 | CN102574837A Novel 5-fluorouracil derivative |
| 07/11/2012 | CN102574836A Aminopyrazole derivative |
| 07/11/2012 | CN102574835A Compounds useful for treating cancer |
| 07/11/2012 | CN102574825A Thiazoles as cannabinoid receptor ligands |
| 07/11/2012 | CN102574824A Desferrithiocin polyether analogues and uses thereof |
| 07/11/2012 | CN102574822A Compounds as lysophosphatidic acid receptor antagonists |
| 07/11/2012 | CN102574816A Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 07/11/2012 | CN102574804A Quinolinyloxyphenylsulfonamides |
| 07/11/2012 | CN102574787A Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity |
| 07/11/2012 | CN102574786A Dihydroorotate dehydrogenase inhibitors |
| 07/11/2012 | CN102574782A Substituted halophenoxybenzamide derivatives |
| 07/11/2012 | CN102573994A Novel bicyclic urea compounds |
| 07/11/2012 | CN102573923A Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 07/11/2012 | CN102573917A Pegylated L-asparaginase |
| 07/11/2012 | CN102573916A Uses of immunoconjugates targeting cd138 |
| 07/11/2012 | CN102573910A Targeted nano-photomedicines for photodynamic therapy of cancer |
| 07/11/2012 | CN102573909A Anti-angiogenesis therapy for the treatment of previously treated breast cancer |
| 07/11/2012 | CN102573877A Methods of treating cancer using neurotrophin retargeted endopeptidases |
| 07/11/2012 | CN102573876A Methods of treating cancer using galanin retargeted endpeptidases |
| 07/11/2012 | CN102573875A Methods of treating cancer using tachykinin retargeted endopeptidases |
| 07/11/2012 | CN102573853A Method of reducing multi-drug resistance using inositol tripyrophosphate |
| 07/11/2012 | CN102573833A Cancer cell apoptosis |
| 07/11/2012 | CN102573826A Pentamidine combinations for treating cancer |
| 07/11/2012 | CN102573819A Heparanase-activity inhibitor, wrinkle ameliorating agent containing same, and pharmaceutical composition |
| 07/11/2012 | CN102559895A Application of human Nin one binding (NOB1) gene and related medicine |
| 07/11/2012 | CN102559828A Method for preparing astragaloside IV by converting total saponins of astragalus by microorganisms |
| 07/11/2012 | CN102559753A IL-24 and OSM double-gene co-expression recombinant plasmid, recombinant adenovirus and application |
| 07/11/2012 | CN102559687A Spindle centromere associated protein Z (CENP-Z) and encoded gene as well as application thereof |
| 07/11/2012 | CN102559636A Antibody fusion protein used for leukemia and autoimmune disease and preparation method thereof |
| 07/11/2012 | CN102559598A Preparation and detection method for heat shock apoptosis intracranial glioma cells |
| 07/11/2012 | CN102558565A Polyethylene glycol monomethyl ether-polycaprolactone-polyphosphate copolymer and application thereof |
| 07/11/2012 | CN102558393A Preparation process of dalteparin sodium |
| 07/11/2012 | CN102558391A Vitamin E succinate-chitosan graft and preparation method and application thereof |
| 07/11/2012 | CN102558363A Polypeptide carrier for improving medicament/gene tumor targeting and transfection efficiency and application |
| 07/11/2012 | CN102558360A Trypsin inhibitor and preparation method and application thereof |
| 07/11/2012 | CN102558359A Recombinant fusion toxin VEGF165-melittin and preparation method and application thereof |
| 07/11/2012 | CN102558355A Heterodimeric FC (fragment crystallizable) modification method based on charge network and preparation method of heterodimeric proteins |
| 07/11/2012 | CN102558352A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 07/11/2012 | CN102558351A Anti to human alkaline fibroblast growth factor human s c F v antibody and application thereof |
| 07/11/2012 | CN102558336A PRR11 gene and coded protein and application thereof |
| 07/11/2012 | CN102558333A Giant panda ribosomal subunit gene RPL23a recombinant protein and application thereof in preparing anti-cancer drugs |
| 07/11/2012 | CN102558331A tRNA (transfer ribose nucleic acid) binding protein participated in cell cycle regulation and coding gene and application thereof |
| 07/11/2012 | CN102558330A Midkine inhibitory peptide and application thereof |
| 07/11/2012 | CN102558300A Polypeptides capable of antagonizing corticotropin-releasing factor receptors 1 and application of polypeptides |
| 07/11/2012 | CN102558296A Mytilus edulis enzymolysis polypeptide and preparation method and application thereof |
| 07/11/2012 | CN102558282A 一种熊果酸衍生物及其制备方法 One kind of ursolic acid derivative and its preparation method |
| 07/11/2012 | CN102558279A Synthesis and anti-tumor activity research of ursolic acid-3'-substituted propanol ester derivatives |
| 07/11/2012 | CN102558277A Synthesis method of titerpene saponin compound stryphnoside A |
| 07/11/2012 | CN102558275A Alpha type polycrystalline abiraterone acetate crystal, and preparation method, application and pharmaceutical composition thereof |
| 07/11/2012 | CN102558270A 20(S) and 20(R)-dammarane-3beta,12beta,20,25-tetrol derivative and preparation method and application thereof |
| 07/11/2012 | CN102558263A Doxifluridine derivative and preparation method and pharmaceutical application thereof |
| 07/11/2012 | CN102558261A Nucleotide analogue and synthesis and application thereof |
| 07/11/2012 | CN102558258A Strictosidine lactam alkaloid and preparation method and application thereof |
| 07/11/2012 | CN102558222A Resveratrol germanium sesquioxide compound, preparation method thereof and application thereof |
| 07/11/2012 | CN102558200A Vinblastine derivative, preparation method of vinblastine derivative, and application of vinblastine derivative in medicines |
| 07/11/2012 | CN102558193A Gambogenic acid derivatives, and preparation method and application thereof |
| 07/11/2012 | CN102558187A Tetrahydroporphin compound and preparation method and application thereof |
| 07/11/2012 | CN102558185A Pyrido-pyrrole triazine compound, and preparation method and application thereof |
| 07/11/2012 | CN102558178A Tabersonine derivative, pharmaceutical compositions, preparing method and medical application thereof |
| 07/11/2012 | CN102558173A Compound inhibiting conduction of WNT signal, and composition and application thereof |
| 07/11/2012 | CN102558172A 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds, dimer compounds of 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds, and preparation method and use of 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds and dimer compounds of 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds |
| 07/11/2012 | CN102558164A Benzopyrone estrogen receptor (ER) modulator |
| 07/11/2012 | CN102558160A 4-substituted p-methyl sulfonamide anilino-quinazoline derivatives and preparation method and application thereof |
| 07/11/2012 | CN102558159A 4-subsittution m sulfonylurea amide aniline-quinazoline derivate and preparation method and application thereof |
| 07/11/2012 | CN102558147A Compound, and preparation method and application thereof |
| 07/11/2012 | CN102558144A Aryl urea derivatives |
| 07/11/2012 | CN102558143A Derivant III of natural product Bostrycin and preparation method and purpose thereof |
| 07/11/2012 | CN102558130A 2-(4-fluorine phenyl)-3-nitryl-8-ethyoxyl-2H-benzopyran chiral compound and preparation method and application thereof |
| 07/11/2012 | CN102558125A 3-acetyl-Amino-7-hydroxy-6-methoxy coumarin derivative, preparing method and application thereof |
| 07/11/2012 | CN102558091A Benzothiazole derivative and application thereof |
| 07/11/2012 | CN102558081A Preparation method of N1, N4-duel substitution phenyl group-3, 6-dimethyl-1,2,4,5-tetrazine-1,4-dimethyl amide |
| 07/11/2012 | CN102558058A 1-aryl-3-substituent-5-substituted amino-4-pyrazole formamide compound and application thereof |
| 07/11/2012 | CN102558049A Dicoumarol compound, as well as preparation method and application thereof |
| 07/11/2012 | CN102558022A Substituted isoindoline-1,3-dione derivative |
| 07/11/2012 | CN102557998A Method for synthesizing anti-form stilbene compounds and application of method in preparing anti-tumor medicines |
| 07/11/2012 | CN102557983A (4-substituted benzoyl) fluorobenzene salicylamide compound and application thereof |
| 07/11/2012 | CN102557982A Certain chemical entities, compositions, and methods |
| 07/11/2012 | CN102557979A Agomelatine crystal form, as well as preparation method, application and medicinal composition thereof |
| 07/11/2012 | CN102557977A Synthesis intermediate of erlotinib and preparation method thereof |
| 07/11/2012 | CN102557969A Cyclic ketone derivatives and applications thereof as developers and aggregation inhibitors of amyloid protein sediments and neurofibrillary tangles |
| 07/11/2012 | CN102557942A Steviol derivative, and preparation method and application thereof |
| 07/11/2012 | CN102557914A Naphthazarin nucleus oxialkyl and acyl substituted alkannin derivative, its preparation and application thereof |
| 07/11/2012 | CN102557885A Novel diphenylbutadiene derivative and applications thereof in drug |
| 07/11/2012 | CN102552948A Controllable release composition and method for preparing same |
| 07/11/2012 | CN102552946A Double-mode imaging and medicine-loading integrated nano medicine carrier and preparation method thereof |
| 07/11/2012 | CN102552937A Application of human p21-activated kinase 7 (PAK7) gene and relevant medicines of human PAK7 gene |
| 07/11/2012 | CN102552936A siRNA (small-interfering RNA) vector complex for gene-targeted delivery and preparation method of the complex |
| 07/11/2012 | CN102552934A Adriamycin nano-particles and preparation method thereof |
| 07/11/2012 | CN102552933A 蛋氨酸酶在抗蛋氨酸和抗高半胱氨酸的化学治疗中的应用 Methioninase used in chemotherapy anti-methionine and homocysteine in the anti- |
| 07/11/2012 | CN102552932A Method for preparing graphene oxide double-targeting medicine carrier material, and loaded medicine |
| 07/11/2012 | CN102552930A Water-soluble paclitaxel derivative with cell targeting effect and preparation thereof |
| 07/11/2012 | CN102552929A Method for enhancing targeting selectivity of administration system by modifying cell penetrating peptide |
| 07/11/2012 | CN102552928A Double-stage targeted drug delivery system curing brain tumor and preparation method of same |